Why the study?
Does Org 6001 prevent dysrhythmias compared to mexiletine in anaesthetized rats with acute coronary artery ligation?
Does Org 6001 prevent dysrhythmias compared to mexiletine in anaesthetized rats with acute coronary artery ligation?
Org 6001 demonstrates a longer duration of antidysrhythmic action and prevents the decrease in ventricular fibrillation threshold following coronary ligation compared to mexiletine in a rat model.
May indicate longer antidysrhythmic action for Org 6001 in rat ischemia; leaves open translation to clinical arrhythmia prevention.
1 The antidysrhythmic and haemodynamic effects of the aminosteroid, Org 6001, were studied in the rat anaesthetized with pentobarbitone. Mexiletine was used for comparison. 2 Both Org 6001 (2--10 mg/kg) and mexiletine (1 mg/kg) given intravenously antagonized the development of dysrhythmias evoked by acute coronary artery ligation in rats. 3 In antidysrhythmic doses, Org 6001 and mexiletine exerted only moderate and transient hypotension and depression of cardiac contractility (assessed from LV dP/dtmax). Org 6001 did, however, induce a more sustained bradycardia. 4 Effective oral doses of Org 6001 (20--100 mg/kg) were similar to those of mexiletine, disopyramide and propafenone. 5 Oral Org 6001 (100 mg/kg) was effective for 18 h whereas mexiletine (100 mg/kg) failed to protect against evoked dysrhythmias 3 h after dosing. 6 Org 6001 and mexiletine differed in their actions on ventricular fibrillation threshold (VFT). Org 6001 (100 mg/kg orally 12 h before ligation) prevented the decrease in VFT produced by coronary ligation whereas mexiletine (100 mg/kg orally) had no effect. When administered intravenously, mexiletine (but not ORg 6001) increased VFT in normal ventricular muscle.
No takes yet. Share an insight, caveat, or question.
Marshall et al. (1981) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: